Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blanchette

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Journal of the American Veterinary Medical Association|January 23, 2019
Evaluation of sutureless scrotal castration for pediatric and juvenile dogsKirk P Miller, Wendi L Rekers, Lena G DeTar, et al.
Journal of Managed Care & Specialty Pharmacy|November 9, 2020
Economic value of nonsurgical weight loss in adults with obesityYuchen Ding, Xiaozhou Fan, Christopher M Blanchette, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the USRobert Sandhaus, Charlie Strange, Glenda Stone, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 12, 2011
Economic burden of chronic bronchitis in the United States: a retrospective case-control studyChristopher M Blanchette, Melissa H Roberts, Hans Petersen, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 3, 2006
Potential benefits and problems with computerized prescriber order entry: analysis of a voluntary medication error-reporting databaseChunliu Zhan, Rodney W Hicks, Christopher M Blanchette, et al.
Current Medical Research and Opinion|May 8, 2009
Cost and utilization of COPD and asthma among insured adults in the USChristopher M Blanchette, Michael Broder, Caron Ory, et al.
Journal of Medical Economics|March 24, 2017
Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney diseaseL A Clark, S Whitmire, S Patton, et al.
Diabetes Research and Clinical Practice|January 21, 2014
Diabetes complications and adverse health outcomes after coronary revascularizationBola F Ekezue, S B Laditka, J N Laditka, et al.
Clinical Therapeutics|March 1, 2011
Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysisChristopher W Craver, Miriam Tarallo, Craig S Roberts, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 3, 2011
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claimsDouglas W Mapel, Anand A Dalal, Christopher M Blanchette, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Journal of the American Veterinary Medical Association|January 23, 2019
Evaluation of sutureless scrotal castration for pediatric and juvenile dogsKirk P Miller, Wendi L Rekers, Lena G DeTar, et al.
Journal of Managed Care & Specialty Pharmacy|November 9, 2020
Economic value of nonsurgical weight loss in adults with obesityYuchen Ding, Xiaozhou Fan, Christopher M Blanchette, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the USRobert Sandhaus, Charlie Strange, Glenda Stone, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 12, 2011
Economic burden of chronic bronchitis in the United States: a retrospective case-control studyChristopher M Blanchette, Melissa H Roberts, Hans Petersen, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 3, 2006
Potential benefits and problems with computerized prescriber order entry: analysis of a voluntary medication error-reporting databaseChunliu Zhan, Rodney W Hicks, Christopher M Blanchette, et al.
Current Medical Research and Opinion|May 8, 2009
Cost and utilization of COPD and asthma among insured adults in the USChristopher M Blanchette, Michael Broder, Caron Ory, et al.
Journal of Medical Economics|March 24, 2017
Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney diseaseL A Clark, S Whitmire, S Patton, et al.
Diabetes Research and Clinical Practice|January 21, 2014
Diabetes complications and adverse health outcomes after coronary revascularizationBola F Ekezue, S B Laditka, J N Laditka, et al.
Clinical Therapeutics|March 1, 2011
Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysisChristopher W Craver, Miriam Tarallo, Craig S Roberts, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 3, 2011
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claimsDouglas W Mapel, Anand A Dalal, Christopher M Blanchette, et al.
Pageof 12